CellAegis meldet Abschluss der Patientenrekrutierung in der ersten nordamerikanischen Studie zu innovativer Therapie von Herzinfarkten mit autoRIC®
September 11, 2018 12:11 ET
|
CellAegis Devices Inc.
TORONTO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. („CellAegis“ oder das „Unternehmen“), ein Unternehmen, das im Bereich für medizinische Geräte mit kommerzieller Anwendungsreife...
CellAegis annonce l’achèvement de l’inscription de patients à la première étude nord-américaine pour un traitement innovant de la crise cardiaque utilisant le dispositif autoRIC®
September 11, 2018 12:11 ET
|
CellAegis Devices Inc.
TORONTO, 11 sept. 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (« CellAegis » ou la « Société »), entreprise de dispositifs médicaux qui commercialise des solutions novatrices, non invasives,...
CellAegis Announces Completion of Patient Enrollment in First North American Study for Innovative Heart Attack Therapy Using autoRIC®
September 11, 2018 08:30 ET
|
CellAegis Devices Inc.
TORONTO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and...
CellAegis Announces Completion of Patient Enrollment in UK Investigator Sponsored Clinical Trial using autoRIC® Device
June 14, 2018 07:00 ET
|
CellAegis Devices Inc.
TORONTO, June 14, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and...
CellAegis Announces Completion of Patient Enrollment in Danish Investigator Sponsored Clinical Trial Using autoRIC® Device
May 17, 2018 07:00 ET
|
CellAegis Devices Inc.
TORONTO, May 17, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective...
CellAegis Announces First Distribution Agreement for autoRIC® in Europe
April 24, 2018 07:00 ET
|
CellAegis Devices Inc.
TORONTO, April 24, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis”) a commercial-stage medical device company advancing innovative, non-invasive, safe and cost-effective solutions for...
CellAegis Strengthens Management Team to Support Future Growth
April 17, 2018 07:00 ET
|
CellAegis Devices Inc.
TORONTO, April 17, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and...
CellAegis Announces First Patients Enrolled in U.S. SHIELD Pivotal Clinical Trial
April 10, 2018 07:00 ET
|
CellAegis Devices Inc.
TORONTO, April 10, 2018 (GLOBE NEWSWIRE) -- CellAegis Devices Inc. (“CellAegis” or the “Company”), a commercial-stage medical device company advancing innovative, non-invasive, safe and...